{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:48:59Z","timestamp":1795124939991,"version":"4.10.3"},"reference-count":464,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0620-0790-HUJ"],"award-info":[{"award-number":["TA-GT-0620-0790-HUJ"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1778\/20"],"award-info":[{"award-number":["1778\/20"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015798","name":"SBA Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.preteyeres.2021.101029","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:51:53Z","timestamp":1637841113000},"page":"101029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":228,"special_numbering":"C","title":["Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities"],"prefix":"10.1016","volume":"89","author":[{"given":"Nina","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7983-8249","authenticated-orcid":false,"given":"Yogapriya","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-4638","authenticated-orcid":false,"given":"Prakadeeswari","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avigail","family":"Beryozkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-2721","authenticated-orcid":false,"given":"Mor","family":"Hanany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-4198","authenticated-orcid":false,"given":"Erez Y.","family":"Levanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Banin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Ben-Aroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1789-5811","authenticated-orcid":false,"given":"Dror","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2021.101029_bib1","first-page":"1","article-title":"Update on gene therapy clinical trials for choroideremia and potential experimental therapies","volume":"57","author":"Abbouda","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib2","series-title":"Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes","first-page":"236","author":"Abu-safieh","year":"2013"},{"key":"10.1016\/j.preteyeres.2021.101029_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.aax7063","article-title":"A cytosine deaminase for programmable single-base RNA editing","volume":"365","author":"Abudayyeh","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12883-017-0948-5","article-title":"Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy","volume":"17","author":"Adams","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-17121-0_18","article-title":"Different mutations in ELOVL4 affect very long chain fatty acid biosynthesis to cause variable neurological disorders in humans","volume":"854","author":"Agbaga","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.01.002","article-title":"The ArgusTM II retinal prosthesis: factors affecting patient selection for implantation","volume":"36","author":"Ahuja","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41433-020-01286-z","article-title":"Adaptive optics: principles and applications in ophthalmology","volume":"35","author":"Akyol","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101029_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/eye.2008.427","article-title":"Phenotypic progression in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene","volume":"23","author":"Al-Maskari","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101029_bib11","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1167\/iovs.09-3982","article-title":"CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy","volume":"50","author":"Aleman","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ejhg.5201138","article-title":"Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and\/or auditory impairments","volume":"12","author":"Aller","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ejhg.2010.14","article-title":"The USH2A c.2299delG mutation: dating its common origin in a Southern European population","volume":"18","author":"Aller","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1353\/pbm.1970.0011","article-title":"The use of DNA for gene therapy\u2013the need, experimental approach, and implications","volume":"14","author":"Aposhian","year":"1970","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"Ardlie","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajhg.2016.10.008","article-title":"Mutations in REEP6 cause autosomal-recessive retinitis pigmentosa","volume":"99","author":"Arno","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22042092","article-title":"Gene correction recovers phagocytosis in retinal pigment epithelium derived from retinitis pigmentosa-human-induced pluripotent stem cells","volume":"22","author":"Artero-Castro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.10.002","article-title":"The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy","volume":"62","author":"Athanasiou","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12035-012-8245-1","article-title":"Primary skin fibroblasts as a model of Parkinson's disease","volume":"46","author":"Auburger","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib22","first-page":"1","article-title":"Presentation of complex homozygous allele in ABCA4 gene in a patient with retinitis pigmentosa","volume":"2015","author":"Audere","year":"2015","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib23","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1167\/iovs.07-0736","article-title":"A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews","volume":"48","author":"Auslender","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib24","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1167\/iovs.07-0865","article-title":"CERKL mutations and associated phenotypes in seven Spanish families with autosomal recessive retinitis pigmentosa","volume":"49","author":"Avila-Fernandez","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrm.2015.27","article-title":"Pluripotent stem cells in disease modelling and drug discovery","volume":"17","author":"Avior","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib26","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1167\/iovs.14-14544","article-title":"Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter","volume":"55","author":"Bacchi","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature04370","article-title":"Dissection of epistasis in oligogenic Bardet-Biedl syndrome","volume":"439","author":"Badano","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib28","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/ajmg.a.31642","article-title":"A non-ancestral RPGR missense mutation in families with either recessive or semi-dominant X-linked retinitis pigmentosa","volume":"143","author":"Banin","year":"2007","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib31","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/hum.2010.047","article-title":"Molecular anthropology meets genetic medicine to treat blindness in the North African jewish population: human gene therapy initiated in Israel","volume":"21","author":"Banin","year":"2010","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/mt.2015.114","article-title":"Gene augmentation therapy restores retinal function and visual behavior in a sheep model of CNGA3 achromatopsia","volume":"23","author":"Banin","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib33","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.1214707110","article-title":"Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration","volume":"110","author":"Barabas","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2021.101029_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/genes10050368","article-title":"AON-mediated exon skipping to bypass protein truncation in retinal dystrophies due to the recurrent CEP290 c.4723A > T mutation. Fact or fiction?","volume":"10","author":"Barny","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib35","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"71","author":"Bass","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib38","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib39","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41436-018-0420-y","article-title":"ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants","volume":"21","author":"Bauwens","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/humu.22608","article-title":"Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots","volume":"35","author":"Baux","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2021.101029_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1101\/gr.164749.113","article-title":"A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes","volume":"24","author":"Bazak","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jmedgenet-2019-106473","article-title":"Gene editing prospects for treating inherited retinal diseases","volume":"57","author":"Benati","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib43","first-page":"2535","article-title":"Adenovirus vector-mediated in vivo gene transfer into adult murine retina","volume":"35","author":"Bennett","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mt.2015.11","article-title":"Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa","volume":"23","author":"Berger","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib45","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1136\/jmg.40.1.e8","article-title":"Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation","volume":"40","author":"Bernal","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/genes8100277","article-title":"Further insights into the ciliary gene and protein KIZ and its murine ortholog PLK1S1 mutated in rod-cone dystrophy","volume":"8","author":"Shamieh","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nsmb825","article-title":"Control of human potassium channel inactivation by editing of a small mRNA hairpin","volume":"11","author":"Bhalla","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib48","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","article-title":"Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells","volume":"14","author":"Bidou","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1006\/exer.2001.1093","article-title":"Visual function in patients with cone-rod dystrophy (CRD) associated with mutations in the ABCA4(ABCR) gene","volume":"73","author":"Birch","year":"2001","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207958","article-title":"Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa","volume":"13","author":"Birtel","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2021.101029_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gde.2018.05.001","article-title":"Synthetic transcription factors for cell fate reprogramming","volume":"52","author":"Black","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.preteyeres.2021.101029_bib52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0888-7543(91)90008-3","article-title":"Linkage mapping of autosomal dominant retinitis pigmentosa (RP1) to the pericentric region of human chromosome 8","volume":"11","author":"Blanton","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.preteyeres.2021.101029_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5614","article-title":"A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation","volume":"6","author":"B\u00f6hm","year":"2020","journal-title":"Sci. Adv"},{"key":"10.1016\/j.preteyeres.2021.101029_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/genes10040278","article-title":"Correction of NR2E3 associated enhanced S-cone syndrome patient-specific IPSCS using CRISPR-cas9","volume":"10","author":"Bohrer","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib55","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41598-018-22093-3","article-title":"Landscape of the spliced leader trans-splicing mechanism in Schistosoma mansoni","volume":"8","author":"Boroni","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib56","doi-asserted-by":"crossref","unstructured":"Botto, C., Rucli, M., Tekinsoy, M.D., Pulman, J., Sahel, J.-A., Dalkara, D., 2021. Early and late stage gene therapy interventions for inherited retinal degenerations. Prog. Retin. Eye Res. 100975 (in press).","DOI":"10.1016\/j.preteyeres.2021.100975"},{"key":"10.1016\/j.preteyeres.2021.101029_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004390100461","article-title":"A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants","volume":"108","author":"Boycott","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13816810.2011.565397","article-title":"Allelic and phenotypic heterogeneity in ABCA4 mutations","volume":"32","author":"Burke","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib59","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.preteyeres.2018.03.003","article-title":"CRISPR-Cas9 genome engineering: treating inherited retinal degeneration","volume":"65","author":"Burnight","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav3335","article-title":"In vivo genome editing rescues photoreceptor degeneration via a Cas9\/RecA-mediated homology-directed repair pathway","volume":"5","author":"Cai","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2021.101029_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.preteyeres.2017.09.003","article-title":"Manipulating ocular endothelial tight junctions: applications in treatment of retinal disease pathology and ocular hypertension","volume":"62","author":"Campbell","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib63","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1534\/genetics.111.131433","article-title":"Genome engineering with zinc-finger nucleases","volume":"188","author":"Carroll","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.preteyeres.2021.101029_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exer.2013.02.006","article-title":"ABCA4 mutational spectrum in Mexican patients with Stargardt disease: identification of 12 novel mutations and evidence of a founder effect for the common p.A1773V mutation","volume":"109","author":"Chac\u00f3n-Camacho","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","volume":"33","author":"Chan","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib69","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jmb.2015.10.014","article-title":"Origins of programmable nucleases for genome engineering","volume":"428","author":"Chandrasegaran","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","article-title":"The Nonsense-mediated decay RNA surveillance pathway","volume":"76","author":"Chang","year":"2007","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.preteyeres.2021.101029_bib71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nmeth.3312","article-title":"Highly efficient Cas9-mediated transcriptional programming","volume":"12","author":"Chavez","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.preteyeres.2021.101029_bib72","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.96.26.15149","article-title":"Retina-specific nuclear receptor: A potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Muller glial cells","volume":"96","author":"Chen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2021.101029_bib73","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S1355838200000170","article-title":"A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains","volume":"6","author":"Chen","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.preteyeres.2021.101029_bib74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1523\/JNEUROSCI.3571-04.2005","article-title":"The rod photoreceptor-specific nuclear receptor Nr2e3 represses transcription of multiple cone-specific genes","volume":"25","author":"Chen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib75","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/hmg\/ddh173","article-title":"Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors","volume":"13","author":"Cheng","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib76","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","article-title":"Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo","volume":"23","author":"Chiaradia","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib77","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1101\/gr.246900.118","article-title":"Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance","volume":"29","author":"Chung","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib78","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2021.101029_bib79","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2021.101029_bib80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib81","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1167\/iovs.11-9064","article-title":"Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration","volume":"53","author":"Cloutier","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICU.0000000000000363","article-title":"Applications of antisense oligonucleotides for the treatment of inherited retinal diseases","volume":"28","author":"Collin","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib83","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/mtna.2012.3","article-title":"Antisense oligonucleotide (AON)-based therapy for leber congenital amaurosis caused by a frequent mutation in CEP290","volume":"1","author":"Collin","year":"2012","journal-title":"Mol. Ther. - Nucle. Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.62.2.13","article-title":"Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome","volume":"62","author":"Colombo","year":"2021","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib85","first-page":"2801","article-title":"Dominant and recessive mutations in rhodopsin activate different cell death pathways","volume":"25","author":"Comitato","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/518426","article-title":"Recurrent mutation in the first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa","volume":"81","author":"Coppieters","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib87","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1002\/humu.21336","article-title":"Genetic screening of LCA in Belgium: Predominance of CEP290 and identification of potential modifier alleles in AHI1 of CEP290-related phenotypes","volume":"31","author":"Coppieters","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2021.101029_bib88","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1566523211313020008","article-title":"Translating Induced Pluripotent Stem Cells from Bench to Bedside: Application to Retinal Diseases","volume":"13","author":"Cramer","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/7.3.355","article-title":"Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR","volume":"7","author":"Cremers","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib91","doi-asserted-by":"crossref","first-page":"100861","DOI":"10.1016\/j.preteyeres.2020.100861","article-title":"Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations","volume":"79","author":"Cremers","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib92","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/humu.24100","article-title":"Functional analysis and classification of homozygous and hypomorphic ABCA4 variants associated with Stargardt macular degeneration","volume":"41","author":"Curtis","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2021.101029_bib93","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular Mechanisms and Biological Functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1741-7015-8-42","article-title":"Zinc Finger Nucleases as tools to understand and treat human diseases","volume":"8","author":"Davis","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.756","article-title":"TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum","volume":"43","author":"Davis","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib97","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1242\/jcs.00371","article-title":"Dynamic association of RNA-editing enzymes with the nucleolus","volume":"116","author":"Desterro","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052607","article-title":"Allele-specific knockout by crispr\/cas to treat autosomal dominant retinitis pigmentosa caused by the g56r mutation in nr2e3","volume":"22","author":"Diakatou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib99","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives","volume":"63","author":"Dias","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omtn.2018.05.014","article-title":"Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA","volume":"12","author":"Dooley","year":"2018","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib101","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cells8050403","article-title":"Current challenges of ipsc-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2021.101029_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11121497","article-title":"Genetic and clinical findings in an ethnically diverse cohort with retinitis pigmentosa associated with pathogenic variants in cerkl","volume":"11","author":"Downes","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib103","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/321269","article-title":"A common ancestral origin of the frequent and widespread 2299delG USH2A mutation","volume":"69","author":"Dreyer","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib104","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/347614a0","article-title":"Human genetics. Deficiencies in sight with the candidate gene approach","volume":"347","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib105","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM199011083231903","article-title":"Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa","volume":"323","author":"Dryja","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib106","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/343364a0","article-title":"A point mutation of the rhodopsin gene in one form of retinitis pigmentosa","volume":"343","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng0793-280","article-title":"Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness","volume":"4","author":"Dryja","year":"1993","journal-title":"Nat.Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib108","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease Modeling in Stem Cell-Derived 3D Organoid Systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib109","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI39715","article-title":"PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome","volume":"120","author":"Ebermann","year":"2010","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.preteyeres.2021.101029_bib110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncomms1324","article-title":"Predicting sites of ADAR editing in double-stranded RNA","volume":"2","author":"Eggington","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2021.101029_bib111","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","article-title":"A-to-I RNA editing - Immune protector and transcriptome diversifier","volume":"19","author":"Eisenberg","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib112","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmedgenet-2016-103837","article-title":"Molecular findings from 537 individuals with inherited retinal disease","volume":"53","author":"Ellingford","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib114","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1167\/iovs.11-8693","article-title":"Double concentric autofluorescence ring in NR2E3-p.G56R-linked autosomal dominant retinitis pigmentosa","volume":"53","author":"Escher","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib115","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1126\/science.280.5370.1753","article-title":"Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa","volume":"280","author":"Eudy","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib116","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1038\/s41598-018-33810-3","article-title":"A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies","volume":"8","author":"Ezquerra-Inchausti","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib117","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/humu.23890","article-title":"Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4","volume":"40","author":"Fadaie","year":"2019","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib118","first-page":"941","article-title":"Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline\u2013--histidine substitution (codon 23) in pedigrees from Europe","volume":"47","author":"Farrar","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib119","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1159\/000303360","article-title":"A propos de deux cas de degenerescence hyaloideoretinienne","volume":"135","author":"Favre","year":"1958","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2021.101029_bib120","doi-asserted-by":"crossref","first-page":"12042","DOI":"10.1021\/bi00163a012","article-title":"Kinetics of Intermolecular Cleavage by Hammerhead Ribozymes","volume":"31","author":"Fedor","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.preteyeres.2021.101029_bib121","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/aos.12486","article-title":"Prevalence of Rhodopsin mutations in autosomal dominant Retinitis Pigmentosa in Spain: Clinical and analytical review in 200 families","volume":"93","author":"Fernandez-San Jose","year":"2015","journal-title":"Acta. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib122","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: Aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib123","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamaophthalmol.2019.3278","article-title":"Efficacy and safety of retinal gene therapy using adeno-associated virus vector for patients with choroideremia: a randomized clinical trial","volume":"137","author":"Fischer","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib124","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archopht.117.4.504","article-title":"Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene","volume":"117","author":"Fishman","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archopht.121.6.851","article-title":"ABCA4 gene sequence variations in patients with autosomal recessive cone-rod dystrophy","volume":"121","author":"Fishman","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib126","doi-asserted-by":"crossref","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","article-title":"Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin","volume":"8","author":"Floquet","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib127","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/biom5020893","article-title":"RNA-binding proteins: Splicing factors and disease","volume":"5","author":"Fredericks","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.preteyeres.2021.101029_bib128","first-page":"3576","article-title":"Effects of pathogenic variations in the human rhodopsin gene (Hrho) on the predicted accessibility for a lead candidate ribozyme","volume":"58","author":"Froebel","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/ijms21030777","article-title":"RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences","volume":"21","author":"Fry","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2020.6418","article-title":"Analysis of Pathogenic Variants Correctable with CRISPR Base Editing among Patients with Recessive Inherited Retinal Degeneration","volume":"139","author":"Fry","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib131","doi-asserted-by":"crossref","first-page":"41478","DOI":"10.1038\/srep41478","article-title":"Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-To-I RNA editing","volume":"7","author":"Fukuda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib132","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.omtn.2017.08.003","article-title":"USH2A Gene Editing Using the CRISPR System","volume":"8","author":"Fuster-Garc\u00eda","year":"2017","journal-title":"Mol. Ther. - Nucle. Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/JMN:17:1:35","article-title":"AMPA receptor function is altered in GLUR2-deficient mice","volume":"17","author":"Gaillard","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib134","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/ICU.0b013e328349229e","article-title":"Macular cysts in retinal dystrophy","volume":"22","author":"Ganesh","year":"2011","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib136","series-title":"Prevalence and Genetic \u2013 Phenotypic Characteristics of Patients with USH2A Mutations in a Large Cohort of Chinese Patients with Inherited Retinal Disease","first-page":"87","author":"Gao","year":"2021"},{"key":"10.1016\/j.preteyeres.2021.101029_bib137","doi-asserted-by":"crossref","first-page":"100827","DOI":"10.1016\/j.preteyeres.2019.100827","article-title":"Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives","volume":"77","author":"Garafalo","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib138","first-page":"2552","article-title":"In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery","volume":"25","author":"Garanto","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.11.001","article-title":"Transplantation of photoreceptors into the degenerative retina: Current state and future perspectives","volume":"69","author":"Gasparini","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib140","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1038\/mtna.2012.21","article-title":"AON-mediated exon skipping restores ciliation in fibroblasts harboring the common leber congenital amaurosis CEP290 mutation","volume":"1","author":"Gerard","year":"2012","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib141","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","article-title":"Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial","volume":"135","author":"Ghazi","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib142","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/hmg\/ddx438","article-title":"Cas9\/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery","volume":"27","author":"Giannelli","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib143","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mt.2011.7","article-title":"Gene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR Splice defect in patient-derived cells","volume":"19","author":"Glaus","year":"2011","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib144","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1167\/iovs.10-5741","article-title":"Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina","volume":"51","author":"Goldmann","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/hum.2010.067","article-title":"PTC124-mediated translational readthrough of a nonsense mutation causing usher syndrome type 1C","volume":"22","author":"Goldmann","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib146","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/emmm.201201438","article-title":"A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation","volume":"4","author":"Goldmann","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib147","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1172-7-58","article-title":"Rescue of nonsense mutations by amlexanox in human cells","volume":"7","author":"Gonzalez-Hilarion","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.preteyeres.2021.101029_bib148","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1167\/iovs.10-5781","article-title":"Engineered zinc finger nuclease-mediated homologous recombination of the human rhodopsin gene","volume":"51","author":"Greenwald","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib149","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000325730","article-title":"Pharmacological enhancement of ex vivo gene therapy neuroprotection in a rodent model of retinal degeneration","volume":"47","author":"Gregory-Evans","year":"2011","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI70462","article-title":"Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects","volume":"124","author":"Gregory-Evans","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.preteyeres.2021.101029_bib151","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exer.2008.05.016","article-title":"Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa","volume":"87","author":"Guerin","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib152","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/092986710790514480","article-title":"Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery","volume":"17","author":"Gunaseeli","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib153","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archopht.119.5.745","article-title":"Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration","volume":"119","author":"Guymer","year":"2001","journal-title":"Arch.Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib154","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2014.11.011","article-title":"European medicines agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene","volume":"25","author":"Haas","year":"2015","journal-title":"Neuromuscul. Disord"},{"key":"10.1016\/j.preteyeres.2021.101029_bib155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ejhg.2017.9","article-title":"Diagnostic exome sequencing in 266 Dutch patients with visual impairment","volume":"25","author":"Haer-Wigman","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib156","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/72777","article-title":"Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate","volume":"24","author":"Haider","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib157","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02983018","article-title":"The relative importance of principal and modifying genes in determining some human diseases","volume":"41","author":"Haldane","year":"1941","journal-title":"J. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib470","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1089\/hum.2019.159","article-title":"Helper-dependent adenovirus transduces the human and rat retina but elicits an inflammatory reaction when delivered subretinally in rats","volume":"30","author":"Han","year":"2019","journal-title":"Human Gene Ther."},{"key":"10.1016\/j.preteyeres.2021.101029_bib158","doi-asserted-by":"crossref","first-page":"e52189","DOI":"10.1371\/journal.pone.0052189","article-title":"Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.preteyeres.2021.101029_bib159","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jmedgenet-2018-105971","article-title":"Allele frequency analysis of variants reported to cause autosomal dominant inherited retinal diseases question the involvement of 19% of genes and 10% of reported pathogenic variants","volume":"56","author":"Hanany","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41431-018-0152-0","article-title":"Carrier frequency analysis of mutations causing autosomal-recessive-inherited retinal diseases in the Israeli population","volume":"26","author":"Hanany","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib161","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1073\/pnas.1913179117","article-title":"Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases","volume":"117","author":"Hanany","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib162","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib163","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib164","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucle. Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/wrna.1158","article-title":"Targeting RNA splicing for disease therapy","volume":"4","author":"Havens","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.preteyeres.2021.101029_bib166","first-page":"187","article-title":"Spontaneous resolution of large macular retinoschisis in enhanced s-cone syndrome. Ophthalmic Surg","volume":"47","author":"Hayashi","year":"2016","journal-title":"Lasers Imag. Retin."},{"key":"10.1016\/j.preteyeres.2021.101029_bib167","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/archopht.1981.03930020859009","article-title":"Telangiectasia and Optic Atrophy in Cone-Rod Degenerations","volume":"99","author":"Heckenlively","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib168","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41596-020-00411-2","article-title":"Establishment of human fetal hepatocyte organoids and CRISPR\u2013Cas9-based gene knockin and knockout in organoid cultures from human liver","volume":"16","author":"Hendriks","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.preteyeres.2021.101029_bib169","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-8944-7_13","article-title":"Genome engineering using TALENs","author":"Hensel","year":"2019"},{"key":"10.1016\/j.preteyeres.2021.101029_bib170","doi-asserted-by":"crossref","first-page":"102012","DOI":"10.1016\/j.scr.2020.102012","article-title":"Human corneal limbal organoids maintaining limbal stem cell niche function","volume":"49","author":"Higa","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib171","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0091270006297140","article-title":"Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers","volume":"47","author":"Hirawat","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib172","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib173","series-title":"Inherited retinal disease in Norway \u2013 a characterization of current clinical and genetic knowledge","first-page":"286","author":"Holtan","year":"2020"},{"key":"10.1016\/j.preteyeres.2021.101029_bib174","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ana.20052","article-title":"Readthrough of Dystrophin Stop Codon Mutations Induced by Aminoglycosides","volume":"55","author":"Howard","year":"2004","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib175","doi-asserted-by":"crossref","first-page":"107447","DOI":"10.1016\/j.biotechadv.2019.107447","article-title":"CRISPR technologies for stem cell engineering and regenerative medicine","volume":"37","author":"Hsu","year":"2019","journal-title":"Biotechnol. Adv"},{"key":"10.1016\/j.preteyeres.2021.101029_bib176","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1182\/blood-2010-07-298331","article-title":"Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.preteyeres.2021.101029_bib177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.61.4.31","article-title":"In vivo CRISPR\/Cas9-mediated genome editing mitigates photoreceptor degeneration in a mouse model of X-linked retinitis pigmentosa","volume":"61","author":"Hu","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib178","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/gim.2014.138","article-title":"Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing","volume":"17","author":"Huang","year":"2015","journal-title":"Genet. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib179","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stemcr.2019.09.010","article-title":"Morphological and Molecular Defects in Human Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis","volume":"13","author":"Huang","year":"2019","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.preteyeres.2021.101029_bib180","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1093\/nar\/gkz018","article-title":"Intracellular selection of trans-cleaving hammerhead ribozymes","volume":"47","author":"Huang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib181","series-title":"Molecular and Phenotypic Investigation of a New Zealand Cohort of Childhood-Onset Retinal Dystrophy","first-page":"708","author":"Hull","year":"2020"},{"key":"10.1016\/j.preteyeres.2021.101029_bib182","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13059-020-02193-y","article-title":"A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila","volume":"21","author":"Huynh","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib183","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1016\/j.visres.2006.08.018","article-title":"Retinitis pigmentosa associated with rhodopsin mutations: Correlation between phenotypic variability and molecular effects","volume":"46","author":"Iannaccone","year":"2006","journal-title":"Vision Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib184","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.11.041","article-title":"Gene therapy and DNA delivery systems","volume":"459","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2021.101029_bib185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fcell.2020.00743","article-title":"Pluripotent Stem Cells for the Treatment of Retinal Degeneration: Current Strategies and Future Directions","volume":"8","author":"Ikelle","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib186","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isoenzyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib187","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib188","doi-asserted-by":"crossref","first-page":"e94813","DOI":"10.15252\/embj.201694813","article-title":"RNA editing of Filamin A pre- mRNA regulates vascular contraction and diastolic blood pressure","volume":"37","author":"Jain","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.preteyeres.2021.101029_bib189","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib190","first-page":"1","article-title":"Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy","volume":"9","author":"Jespersgaard","year":"2019"},{"key":"10.1016\/j.preteyeres.2021.101029_bib191","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2014.00025","article-title":"RNA interference gene therapy in dominant retinitis pigmentosa and cone-rod dystrophy mouse models caused by GCAP1 mutations","volume":"7","author":"Jiang","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib192","doi-asserted-by":"crossref","first-page":"e17084","DOI":"10.1371\/journal.pone.0017084","article-title":"Modeling retinal degeneration using patient-specific induced pluripotent stem cells","volume":"6","author":"Jin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2021.101029_bib193","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib194","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1210","article-title":"CRISPR-Cas9\u2013mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis","volume":"5","author":"Jo","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2021.101029_bib195","first-page":"470","article-title":"Next-generation sequencing to solve complex inherited retinal dystrophy: A case series of multiple genes contributing to disease in extended families","volume":"23","author":"Jones","year":"2017","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib196","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: A widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib197","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13816810.2010.535892","article-title":"A novel nonsense mutation in rhodopsin gene in two Indonesian families with autosomal recessive retinitis pigmentosa","volume":"32","author":"Kartasasmita","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib198","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41592-019-0323-0","article-title":"In vivo RNA editing of point mutations via RNA-guided adenosine deaminases","volume":"16","author":"Katrekar","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.preteyeres.2021.101029_bib199","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1126\/science.1063525","article-title":"Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder","volume":"293","author":"Katsanis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib200","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1101\/gr.119628.110","article-title":"Quantitative evaluation of all hexamers as exonic splicing elements","volume":"21","author":"Ke","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib201","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/10409238.2012.694846","article-title":"Suppression of premature termination codons as a therapeutic approach","volume":"47","author":"Keeling","year":"2012","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"Keeling","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2004.024281","article-title":"Novel association of RP1 gene mutations with autosomal recessive retinitis pigmentosa","volume":"42","author":"Khaliq","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib204","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.omtn.2019.02.027","article-title":"Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application","volume":"16","author":"Khan","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib205","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41436-020-0787-4","article-title":"Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics","volume":"22","author":"Khan","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib206","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jmedgenet-2016-103825","article-title":"Identification of genomic deletions causing inherited retinal degenerations by coverage analysis of whole exome sequencing data","volume":"53","author":"Khateb","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib207","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2144\/000112792","article-title":"RNAi mechanisms and applications","volume":"44","author":"Kim","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.preteyeres.2021.101029_bib209","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib210","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1167\/iovs.08-1901","article-title":"Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration","volume":"49","author":"Kitiratschky","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib211","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bjo.83.8.914","article-title":"Phenotypic variations in a family with retinal dystrophy as result of different mutations in the ABCR gene","volume":"83","author":"Klevering","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib212","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1073\/pnas.96.9.4814","article-title":"Identification of a photoreceptor cell-specific nuclear receptor","volume":"96","author":"Kobayashi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib213","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00018-019-03401-0","article-title":"Stem cell-derived kidney organoids: engineering the vasculature","volume":"77","author":"Koning","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a017145","article-title":"Genetic modifiers and oligogenic inheritance","volume":"5","author":"Kousi","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib215","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41588-020-0707-1","article-title":"Evidence for secondary-variant genetic burden and non-random distribution across biological modules in a recessive ciliopathy","volume":"52","author":"Kousi","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib216","first-page":"662","article-title":"Genetic characteristics of retinitis pigmentosa in 1204","author":"Koyanagi","year":"2019","journal-title":"Jpn. Patien."},{"key":"10.1016\/j.preteyeres.2021.101029_bib217","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T","article-title":"Human gene mutation database-a biomedical information and research resource","volume":"15","author":"Krawczak","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib218","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng0994-10","article-title":"Missense rhodopsin mutation in a family with recessive RP","volume":"8","author":"Kumaramanickavel","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib219","doi-asserted-by":"crossref","first-page":"E3295","DOI":"10.1073\/pnas.1212548109","article-title":"Mechanistic insights into editing-site specificity of ADARs","volume":"109","author":"Kuttan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2021.101029_bib220","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-1-4939-7825-0_23","article-title":"Translating antisense technology into a treatment for Huntington's disease","author":"Lane","year":"2018"},{"key":"10.1016\/j.preteyeres.2021.101029_bib221","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.stemcr.2020.05.007","article-title":"Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids","volume":"15","author":"Lane","year":"2020","journal-title":"Stem cell Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib222","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1038\/mtna.2016.92","article-title":"In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR\/Cas9 in the Mouse Retina","volume":"5","author":"Latella","year":"2016","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2021.101029_bib223","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","article-title":"Pharmaceutical therapies to recode nonsense mutations in inherited diseases","volume":"136","author":"Lee","year":"2012","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib224","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preteyeres.2018.08.003","article-title":"Gene therapy for visual loss: Opportunities and concerns","volume":"68","author":"Lee","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/13816810.2019.1660382","article-title":"Modification of the PROM1 disease phenotype by a mutation in ABCA4","volume":"40","author":"Lee","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib226","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddab122","article-title":"Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease","volume":"30","author":"Lee","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib228","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41436-019-0722-8","article-title":"Clinical utility of genetic testing in 201 preschool children with inherited eye disorders","volume":"22","author":"Lenassi","year":"2020","journal-title":"Genet. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib473","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/ejhg.2014.283","article-title":"A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants","volume":"23","author":"Lenassi","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib229","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/cpdd.647","article-title":"Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers","volume":"8","author":"Leubitz","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.preteyeres.2021.101029_bib230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nbt996","article-title":"Systematic identification of abundant A-to-I editing sites in the human transcriptome","volume":"22","author":"Levanon","year":"2004","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib231","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng1386","article-title":"Identification and characterization of rod-derived cone viability factor","volume":"36","author":"Leveillard","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib233","series-title":"Fundamentals of Molecular Evolution. Sinauer Associates, inc","author":"Li","year":"2000"},{"key":"10.1016\/j.preteyeres.2021.101029_bib234","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nbt.2199","article-title":"High-efficiency TALEN-based gene editing produces disease-resistant rice","volume":"30","author":"Li","year":"2012","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"Cris. J."},{"key":"10.1016\/j.preteyeres.2021.101029_bib236","doi-asserted-by":"crossref","first-page":"570917","DOI":"10.3389\/fncel.2020.570917","article-title":"Comparison of CRISPR\/Cas Endonucleases for in vivo Retinal Gene Editing","volume":"14","author":"Li","year":"2020","journal-title":"Front. Cell. Neurosci"},{"key":"10.1016\/j.preteyeres.2021.101029_bib237","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib238","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin","volume":"117","author":"Linde","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.preteyeres.2021.101029_bib239","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652312802083585","article-title":"RNAi-based gene therapy for dominant limb girdle muscular dystrophies","volume":"12","author":"Liu","year":"2012","journal-title":"Curr. Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cge.12181","article-title":"Alternative splicing and retinal degeneration","volume":"84","author":"Liu","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib241","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/genes12060805","article-title":"Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells","volume":"12","author":"Liu","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib242","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4614-0631-0_48","article-title":"Congenital stationary night blindness: Mutation update and clinical variability","volume":"723","author":"Lodha","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249449","article-title":"Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches","volume":"21","author":"Lombardi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib244","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.7992055","article-title":"Control of kinetic properties of AMPA receptor channels by nuclear RNA editing","volume":"266","author":"Lomeli","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2021.101029_bib245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1167\/iovs.13-13278","article-title":"Correction of the Crb1rd8 allele and retinal phenotype in C57BL\/6N mice via TALEN-mediated homology-directed repair","volume":"55","author":"Low","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib246","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/978-981-15-8763-4_38","article-title":"Optogenetic strategies for vision restoration","volume":"1293","author":"Lu","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib247","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1038\/srep12910","article-title":"Human iPSC derived disease model of MERTK-associated retinitis pigmentosa","volume":"5","author":"Lukovic","year":"2015","journal-title":"Sci. Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib248","doi-asserted-by":"crossref","first-page":"108405","DOI":"10.1016\/j.exer.2020.108405","article-title":"Spectrum-frequency and genotype\u2013phenotype analysis of rhodopsin variants","volume":"203","author":"Luo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib249","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1038\/srep09236","article-title":"Whole-exome sequencing identifies OR2W3 mutation as a cause of autosomal dominant retinitis pigmentosa","volume":"5","author":"Ma","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib250","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1093\/nar\/gkp599","article-title":"Identification of a selective nuclear import signal in adenosine deaminases acting on RNA","volume":"37","author":"Maas","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib251","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple Vectors Expand AAV Transfer Capacity in the Retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib252","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib253","first-page":"2240","article-title":"Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis. N. Engl","volume":"358","author":"Maguire","year":"2008","journal-title":"J. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib254","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41586-020-2201-4","article-title":"Pharmacologic fibroblast reprogramming into photoreceptors restores vision","volume":"581","author":"Mahato","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib256","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/jpm10040215","article-title":"A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities","volume":"10","author":"Malankhanova","year":"2020","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib257","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-6866.112870","article-title":"Delivery systems for gene therapy","volume":"19","author":"Mali","year":"2013","journal-title":"Indian J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib258","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1167\/iovs.03-0730","article-title":"Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression","volume":"45","author":"Mallam","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib259","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/ja025557o","article-title":"Efficient RNase H-directed cleavage of RNA promoted by antisense DNA or 2\u2032F-ANA constructs containing acyclic nucleotide inserts","volume":"125","author":"Mangos","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.preteyeres.2021.101029_bib260","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib261","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.preteyeres.2021.101029_bib262","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ophtha.2019.03.018","article-title":"Genomic Landscape of Sporadic Retinitis Pigmentosa: Findings from 877 Spanish Cases","volume":"126","author":"Martin-Merida","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101029_bib263","first-page":"539","article-title":"Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR","volume":"388","author":"Mart\u00ednez-Mir","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib264","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-014-0180-y","article-title":"Therapeutic strategies based on modified u1 snrnas and chaperones for sanfilippo c splicing mutations","volume":"9","author":"Matos","year":"2014","journal-title":"Orphanet J. Rare Dis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fgene.2020.00528","article-title":"Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA","volume":"11","author":"Matsoukas","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib266","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nsmb.3203","article-title":"Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity","volume":"23","author":"Matthews","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib267","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/302323","article-title":"The 2588G-->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease","volume":"64","author":"Maugeri","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib268","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1086\/303079","article-title":"Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy","volume":"67","author":"Maugeri","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc. Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib271","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic Gene Editing of GUCY2D by AAV-CRISPR\/Cas9 Alters Retinal Structure and Function in Mouse and Macaque. Hum","volume":"30","author":"McCullough","year":"2019","journal-title":"Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib272","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/301614","article-title":"Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele","volume":"61","author":"McGee","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib273","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/ceo.12542","article-title":"Genetic analysis of choroideremia families in the Australian population","volume":"43","author":"Mclaren","year":"2015","journal-title":"Clin. Exp. Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib274","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41467-017-00111-8","article-title":"Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models","volume":"8","author":"Megaw","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1016\/j.preteyeres.2021.101029_bib276","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","article-title":"Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides","volume":"37","author":"Merkle","year":"2019","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib277","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.ophtha.2005.04.004","article-title":"Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin\/RDS gene","volume":"112","author":"Michaelides","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101029_bib278","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/mt.2010.149","article-title":"Restoration of cone vision in the CNGA3-\/- mouse model of congenital complete lack of cone photoreceptor function","volume":"18","author":"Michalakis","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib279","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib281","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/6.9.1415","article-title":"Strategems in vitro for gene therapies directed to dominant mutations","volume":"6","author":"Millington-Ward","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib282","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2152\/jmi.59.1","article-title":"Diagnostic imaging in patients with retinitis pigmentosa","volume":"59","author":"Mitamura","year":"2012","journal-title":"J. Med. Investig"},{"key":"10.1016\/j.preteyeres.2021.101029_bib283","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1073\/pnas.1214387110","article-title":"Reprogramming of adult rod photoreceptors prevents retinal degeneration","volume":"110","author":"Montana","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib284","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.1306243110","article-title":"Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing","volume":"110","author":"Montiel-Gonzalez","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib285","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddn302","article-title":"Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease","volume":"17","author":"Moosajee","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib286","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2013.183","article-title":"Clinical utility gene card for: Choroideremia","volume":"22","author":"Moosajee","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib287","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1093\/hmg\/ddw184","article-title":"Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsensemediated zebrafish model","volume":"25","author":"Moosajee","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib288","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib289","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease. Hum","volume":"29","author":"Mort","year":"2008","journal-title":"Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib290","first-page":"15939","article-title":"Relative frequency of inherited retinal dystrophies in Brazil. Sci","volume":"8","author":"Motta","year":"2018","journal-title":"Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib291","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/eye.2014.7","article-title":"A detailed phenotypic description of autosomal dominant cone dystrophy due to a de novo mutation in the GUCY2D gene","volume":"28","author":"Mukherjee","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101029_bib292","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/v12101106","article-title":"Gene therapy applications of non-human lentiviral vectors","volume":"12","author":"Munis","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.preteyeres.2021.101029_bib293","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib294","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/emmm.201000119","article-title":"Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa","volume":"3","author":"Mussolino","year":"2011","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35056009","article-title":"Modifier genes in mice and humans","volume":"2","author":"Nadeau","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib296","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/genes10050363","article-title":"Antisense oligonucleotide-based downregulation of the G56R pathogenic variant causing NR2E3-associated autosomal dominant retinitis pigmentosa","volume":"10","author":"Naessens","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib297","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0952523814000194","article-title":"Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations","volume":"31","author":"Nagel-Wolfrum","year":"2014","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.preteyeres.2021.101029_bib298","first-page":"299","article-title":"A unique PRDM13-associated variant in a Georgian Jewish family with probable North Carolina macular dystrophy and the possible contribution of a unique CFH variant","volume":"26","author":"Namburi","year":"2020","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib299","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19082196","article-title":"Expanding the Mutation Spectrum in ABCA4 : Sixty Novel Disease Causing Variants and Their Associated Phenotype in a Large French Stargardt Cohort","volume":"19","author":"Nassisi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12886-020-01791-5","article-title":"X-linked dominant RPGR gene mutation in a familial Coats angiomatosis","volume":"21","author":"Nebbioso","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib301","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tig.2005.08.005","article-title":"Is there any sense in antisense editing?","volume":"21","author":"Neeman","year":"2005","journal-title":"Trends Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib302","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/acsmedchemlett.8b00472","article-title":"New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery","volume":"9","author":"Ng","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.preteyeres.2021.101029_bib303","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/jcm4040567","article-title":"Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases","volume":"4","author":"Nguyen","year":"2015","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib304","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ajhg.2016.07.009","article-title":"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects","volume":"99","author":"Nikopoulos","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib305","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41467-019-14181-3","article-title":"Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice","volume":"11","author":"Nishiguchi","year":"2020","journal-title":"Nat. Commun"},{"key":"10.1016\/j.preteyeres.2021.101029_bib306","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1016\/j.bmcl.2006.09.013","article-title":"Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations","volume":"16","author":"Nudelman","year":"2006","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.preteyeres.2021.101029_bib307","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib308","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1089\/hum.2018.076","article-title":"Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia. Hum","volume":"29","author":"Ofri","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib309","first-page":"409","article-title":"A more efficient method to generate integration-free human iPS cells. Nat","volume":"8","author":"Okita","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.preteyeres.2021.101029_bib310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s40778-017-0078-4","article-title":"Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration","volume":"3","author":"Ovando-Roche","year":"2017","journal-title":"Curr. Stem Cell Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib311","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1167\/iovs.12-9812","article-title":"Gene repair of an Usher syndrome causing mutation by zinc-finger nuclease mediated homologous recombination","volume":"53","author":"Overlack","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib312","first-page":"2863","article-title":"Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa","volume":"41","author":"O'Neill","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib313","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/gt.2010.29","article-title":"Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency","volume":"17","author":"Pang","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib314","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/156652307779940216","article-title":"Meganucleases and DNA Double-Strand Break-Induced Recombination: Perspectives for Gene Therapy","volume":"7","author":"Paques","year":"2007","journal-title":"Curr. Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","article-title":"Neuroprotective strategies for retinal disease","volume":"65","author":"Pardue","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib316","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.stem.2016.03.021","article-title":"Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups","volume":"18","author":"Parfitt","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib317","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/MCB.15.10.5376","article-title":"Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase","volume":"15","author":"Patterson","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib318","first-page":"533","article-title":"The application of CRISPR\/CAS9 for the treatment of retinal diseases. Yale J","volume":"90","author":"Peddle","year":"2017","journal-title":"Biol. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib320","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/ijms21072329","article-title":"Crispr interference\u2013potential application in retinal disease","volume":"21","author":"Peddle","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib321","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/humu.20417","article-title":"Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: Genotype-phenotype correlations and impact on genetic counseling","volume":"28","author":"Pelletier","year":"2007","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib322","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","article-title":"Ataluren as an agent for therapeutic nonsense suppression","volume":"64","author":"Peltz","year":"2013","journal-title":"Annu. Rev. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib323","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/humu.9259","article-title":"USH2A mutation analysis in 70 Dutch families with Usher syndrome type II","volume":"24","author":"Pennings","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib324","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41598-021-81093-y","article-title":"Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications","volume":"11","author":"Perea-Romero","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2021.101029_bib325","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","article-title":"Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development","volume":"43","author":"Pestal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.preteyeres.2021.101029_bib326","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/nar\/gku1345","article-title":"Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR2","volume":"43","author":"Phelps","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib327","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2015.06.038","article-title":"Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives","volume":"101","author":"Pibiri","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib328","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2016.06.048","article-title":"Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening","volume":"122","author":"Pibiri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib329","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/10305","article-title":"Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause dominant retinitis pigmentosa","volume":"22","author":"Pierce","year":"1999","journal-title":"Nat.Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib330","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2016.01.021","article-title":"Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa","volume":"123","author":"Pierrache","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101029_bib331","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/13816819609057891","article-title":"Full characterization of the maculopathy associated with an Arg-172-Trp mutation in the RDS\/peripherin gene","volume":"17","author":"Piguet","year":"1996","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib332","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1093\/nar\/gkw486","article-title":"An atlas of gene expression and gene co-regulation in the human retina","volume":"44","author":"Pinelli","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib333","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1016\/S0021-9258(20)89528-3","article-title":"The cDNA sequence and the deduced amino acid sequence of human transcobalamin II show homology with rat intrinsic factor and human transcobalamin I","volume":"266","author":"Platica","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2021.101029_bib334","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/380454a0","article-title":"RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase","volume":"380","author":"Polson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib335","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1167\/iovs.08-3208","article-title":"Identification of an intronic single-point mutation in RP2 as the cause of semidominant X-linked retinitis pigmentosa","volume":"50","author":"Pomares","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib336","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/molbev\/msx125","article-title":"A-to-I RNA editing in the earliest-diverging eumetazoan phyla","volume":"34","author":"Porath","year":"2017","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib337","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1128\/MCB.21.22.7862-7871.2001","article-title":"CRM1 Mediates the Export of ADAR1 through a Nuclear Export Signal within the Z-DNA Binding Domain","volume":"21","author":"Poulsen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib338","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","article-title":"Chromatin remodeling at DNA double-strand breaks","volume":"152","author":"Price","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib339","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-\u03b3uided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2021.647400","article-title":"Identification of deep-intronic splice mutations in a large cohort of patients with inherited retinal diseases","volume":"12","author":"Qian","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib341","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00439-007-0410-7","article-title":"In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome","volume":"122","author":"Rebibo-Sabbah","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib342","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/10430340360464697","article-title":"Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy","volume":"14","author":"Reich","year":"2003","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib343","doi-asserted-by":"crossref","unstructured":"Reichel, F.F., Michalakis, S., Wilhelm, B., Zobor, D., Muehlfriedel, R., Kohl, S., Weisschuh, N., Sothilingam, V., Kuehlewein, L., Kahle, N., Seitz, I., Paquet-Durand, F., Tsang, S.H., Martus, P., Peters, T., Seeliger, M., Bartz-Schmidt, K.U., Ueffing, M., Zrenner, E., Biel, M., Wissinger, B., Fischer, D., 2021. Three-year results of phase i retinal gene therapy trial for CNGA3-mutated achromatopsia: Results of a non randomised controlled trial. Br. J. Ophthalmol. (in press).","DOI":"10.1136\/bjophthalmol-2021-319067"},{"key":"10.1016\/j.preteyeres.2021.101029_bib344","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1167\/iovs.04-1280","article-title":"Autosomal Recessive Retinitis Pigmentosa Is Associated with Mutations in RP1 in Three Consanguineous Pakistani Families","volume":"46","author":"Riazuddin","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib345","first-page":"405","volume":"17","author":"Richards","year":"2015","journal-title":"Stand. Guidel. Interpret. Seq. Variants: Joint Consens. Recomm. Am. Coll. Med. Genet. Genom. Assoc. Mol. Pathol. Genet. Med."},{"key":"10.1016\/j.preteyeres.2021.101029_bib346","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2017.01.001","article-title":"Mechanism and evidence of nonsense suppression therapy for genetic eye disorders","volume":"155","author":"Richardson","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib347","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/303090","article-title":"A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration","volume":"67","author":"Rivera","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib348","first-page":"1975","volume":"66","author":"Rivolta","year":"2000","journal-title":"Missense Mut. USH2A Gene: Assoc. Recessive Retinitis Pigmentosa without Hear. Loss. Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib349","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/11.10.1219","article-title":"Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns","volume":"11","author":"Rivolta","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib350","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/humu.20325","article-title":"Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations","volume":"27","author":"Rivolta","year":"2006","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib351","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jmoldx.2020.01.003","article-title":"Expanding the Clinical and Molecular Heterogeneity of Nonsyndromic Inherited Retinal Dystrophies","volume":"22","author":"Rodr\u00edguez-mu\u00f1oz","year":"2020","journal-title":"J. Mol. Diagnostics"},{"key":"10.1016\/j.preteyeres.2021.101029_bib352","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21655979.2018.1470720","article-title":"Crispr-cas systems: Ushering in the new genome editing era","volume":"9","author":"Rojo","year":"2018","journal-title":"Bioengineered"},{"key":"10.1016\/j.preteyeres.2021.101029_bib353","first-page":"563981","article-title":"Kidney Organoids as Disease Models: Strengths, Weaknesses and Perspectives. Front","volume":"11","author":"Romero-Guevara","year":"2020","journal-title":"Physiol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib354","first-page":"1962","article-title":"N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population","volume":"13","author":"Rosenberg","year":"2007","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib355","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng0692-209","article-title":"A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa","volume":"1","author":"Rosenfeld","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib356","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jmg.39.4.284","article-title":"Dominant X linked retinitis pigmentosa is frequently accounted for by truncating mutations in exon ORF15 of the RPGR gene","volume":"39","author":"Rozet","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib357","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib358","first-page":"3220","article-title":"The common ABCA4 variant p.Asn1868ile shows nonpenetrance and variable expression of stargardt disease when present in trans with severe variants. Investig. Ophthalmol","volume":"59","author":"Runhart","year":"2018","journal-title":"Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib359","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-61779-767-5_23","article-title":"Overview of alternative oligonucleotide chemistries for exon skipping","volume":"867","author":"Saleh","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib360","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1167\/iovs.17-22398","article-title":"Novel complex ABCA4 alleles in Brazilian patients with stargardt disease: Genotype-Phenotype Correlation","volume":"58","author":"Salles","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib361","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ajmg.c.31828","article-title":"Clinical and molecular findings in a cohort of 152 Brazilian severe early onset inherited retinal dystrophy patients","volume":"184","author":"Sallum","year":"2020","journal-title":"Am. J. Med. Genet., Part C: Seminars in Medical Genetics"},{"key":"10.1016\/j.preteyeres.2021.101029_bib362","doi-asserted-by":"crossref","first-page":"31842393","DOI":"10.3390\/ijms20246274","article-title":"Ataluren for the treatment of usher syndrome 2A caused by nonsense mutations","volume":"20","author":"Samanta","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib363","series-title":"A comprehensive analysis of choroideremia: From genetic characterization to clinical practice. PLoS One 11, e0151943","author":"Sanchez-Alcudia","year":"2016"},{"key":"10.1016\/j.preteyeres.2021.101029_bib364","doi-asserted-by":"crossref","first-page":"5056279","DOI":"10.1155\/2018\/5056279","article-title":"Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy","volume":"2018","author":"Sanjurjo-Soriano","year":"2018","journal-title":"Neural Plast"},{"key":"10.1016\/j.preteyeres.2021.101029_bib365","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.omtm.2019.11.016","article-title":"Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles","volume":"17","author":"Sanjurjo-Soriano","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2021.101029_bib366","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1038\/srep09965","article-title":"Homozygosity mapping reveals novel and known mutations in Pakistani families with inherited retinal dystrophies","volume":"5","author":"Saqib","year":"2015","journal-title":"Sci. Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib367","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/gb-2012-13-12-252","article-title":"The ADAR protein family","volume":"13","author":"Savva","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib368","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/nar\/gkr1112","article-title":"A novel zinc-finger nuclease platform with a sequence-specific cleavage module","volume":"40","author":"Schierling","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib369","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/humu.21509","article-title":"U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation","volume":"32","author":"Schmid","year":"2011","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/hum.2012.110","article-title":"A gene therapeutic approach to correct splice defects with modified U1 and U6 snRNPs. Hum","volume":"24","author":"Schmid","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib371","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/humu.21096","article-title":"NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)","volume":"30","author":"Schorderet","year":"2009","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib372","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1389450043345092","article-title":"Ribozyme- and Deoxyribozyme-Strategies for Medical Applications. Curr","volume":"5","author":"Schubert","year":"2005","journal-title":"Drug Targets"},{"key":"10.1016\/j.preteyeres.2021.101029_bib373","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/hmg\/ddu509","article-title":"Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells","volume":"24","author":"Schwarz","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib374","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archopht.121.9.1316","article-title":"Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration","volume":"121","author":"Sharon","year":"2003","journal-title":"Arch. Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib375","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/13816810.2015.1081252","article-title":"OR2W3 sequence variants are unlikely to cause inherited retinal diseases","volume":"37","author":"Sharon","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib376","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.preteyeres.2017.10.003","article-title":"Genotype-functional-phenotype correlations in photoreceptor guanylate cyclase (GC-E) encoded by GUCY2D","volume":"63","author":"Sharon","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib377","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/humu.23903","article-title":"A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Hum","volume":"41","author":"Sharon","year":"2020","journal-title":"Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib378","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/108729001317022250","article-title":"Uptake dynamics and retinal tolerance of phosphorothioate oligonucleotide and its direct delivery into the site of choroidal neovascularization through subretinal administration in the rat","volume":"11","author":"Shen","year":"2001","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.preteyeres.2021.101029_bib379","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: A decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.preteyeres.2021.101029_bib380","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.celrep.2017.06.045","article-title":"Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations","volume":"20","author":"Shimada","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib381","first-page":"2411","article-title":"Identification of a novel nonsense mutation in RP1 that causes autosomal recessive retinitis pigmentosa in an Indonesian family","volume":"18","author":"Siemiatkowska","year":"2012","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib382","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/hmg\/dds469","article-title":"iPS cell modeling of best disease: Insights into the pathophysiology of an inherited macular degeneration","volume":"22","author":"Singh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib383","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jop.2020.0016","article-title":"Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness","volume":"37","author":"Singh","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib385","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/nar\/28.17.3361","article-title":"Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains","volume":"28","author":"Smith","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib386","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2741\/2812","article-title":"Splicing fidelity, enhancers, and disease","volume":"13","author":"Solis","year":"2008","journal-title":"Front. Biosci"},{"key":"10.1016\/j.preteyeres.2021.101029_bib387","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(91)90568-J","article-title":"RNA editing in brain controls a determinant of ion flow in glutamate-gated channels","volume":"67","author":"Sommer","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib388","first-page":"397","article-title":"1977. Probable genetic linkage between autosomal dominant retinitis pigmentosa (RP) and amylase (AMY2): evidence of an RP locus on chromosome 1-PubMed","volume":"29","author":"Spence","year":"1977","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib389","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1002\/anie.201206489","article-title":"An RNA-deaminase conjugate selectively repairs point mutations","volume":"51","author":"Stafforst","year":"2012","journal-title":"Angew. Chemie - Int. Ed"},{"key":"10.1016\/j.preteyeres.2021.101029_bib390","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1021\/bi0011577","article-title":"Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R\/G editing site","volume":"39","author":"Stephens","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.preteyeres.2021.101029_bib391","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1360-1385(00)01806-9","article-title":"Post-transcriptional gene silencing: conservation and sequences","volume":"5","author":"Stokes","year":"2000","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib392","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/9722","article-title":"A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy","volume":"22","author":"Stone","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib393","series-title":"Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease 1314\u20131331","author":"Stone","year":"2017"},{"key":"10.1016\/j.preteyeres.2021.101029_bib394","series-title":"RDS functional domains and dysfunction in disease, in: Advances in Experimental Medicine and Biology. pp. 217\u2013222","author":"Stuck","year":"2016"},{"key":"10.1016\/j.preteyeres.2021.101029_bib395","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/10314","article-title":"Mutations in a novel retina-specific gene cause autosomal dominant retinitis pigmentosa","volume":"22","author":"Sullivan","year":"1999","journal-title":"Nat.Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib396","first-page":"102","article-title":"Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa","volume":"8","author":"Sullivan","year":"2002","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib397","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.visres.2007.07.027","article-title":"Versatility of AAV vectors for retinal gene transfer","volume":"48","author":"Surace","year":"2008","journal-title":"Vision Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib398","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib399","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1167\/iovs.09-4367","article-title":"Adenovirus vectors targeting distinct cell types in the retina","volume":"51","author":"Sweigard","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib400","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib401","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature24041","article-title":"Dynamic landscape and regulation of RNA editing in mammals","volume":"550","author":"Tan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib402","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.20861","article-title":"Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA","volume":"30","author":"Tanner","year":"2009","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib403","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1139\/o95-118","article-title":"Translational termination efficiency in both bacteria and mammals is regulated by the base following the stop codon","volume":"73","author":"Tate","year":"1995","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib404","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s41467-018-04048-4","article-title":"RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors","volume":"9","author":"Thakore","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1016\/j.preteyeres.2021.101029_bib405","first-page":"100","volume":"12","author":"Thaler","year":"2006","journal-title":"A selective method for transfection of retinal ganglion cells by retrograde transfer of antisense oligonucleotides against kynurenine aminotransferase II. Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib406","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archopht.1996.01100140158008","article-title":"Clinical and histopathologic findings in clumped pigmentary retinal degeneration","volume":"114","author":"To","year":"1996","journal-title":"Arch.Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib407","doi-asserted-by":"crossref","first-page":"108330","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-retinopathy: From genetics to therapeutics","volume":"201","author":"Toualbi","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib408","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/genes10120959","article-title":"Genetic spectrum of ABCA4-associated retinal degeneration in Poland","volume":"10","author":"Tracewska","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib409","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1093\/nar\/gkz267","article-title":"CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration","volume":"47","author":"Truong","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib410","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101029_bib411","series-title":"Patient-specifc iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. Elife 2, e00824","author":"Tucker","year":"2013"},{"key":"10.1016\/j.preteyeres.2021.101029_bib412","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/381055","article-title":"Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)","volume":"74","author":"Tuson","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib413","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib414","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.molcel.2021.03.024","article-title":"Deciphering the principles of the RNA editing code via large-scale systematic probing","volume":"81","author":"Uzonyi","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib415","first-page":"1023","article-title":"Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation. Ophthalmol","volume":"4","author":"Vaclavik","year":"2020","journal-title":"Retin"},{"key":"10.1016\/j.preteyeres.2021.101029_bib416","first-page":"214","article-title":"Gene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration. Front","volume":"13","author":"Vagni","year":"2019","journal-title":"Neurosci"},{"key":"10.1016\/j.preteyeres.2021.101029_bib417","first-page":"902","article-title":"Microarray-based mutation analysis of the ABCA4 gene in Spanish patients with Stargardt disease: Evidence of a prevalent mutated allele","volume":"12","author":"Valverde","year":"2006","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib418","first-page":"461","article-title":"The efficacy of microarray screening for autosomal recessive retinitis pigmentosa in routine clinical practice","volume":"21","author":"van Huet","year":"2015","journal-title":"Mol. Vis"},{"key":"10.1016\/j.preteyeres.2021.101029_bib419","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/383096","article-title":"Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II","volume":"74","author":"van Wijk","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib420","first-page":"e3779","article-title":"Skin punch biopsy explant culture for derivation of primary human fibroblasts","volume":"77","author":"Vangipuram","year":"2013","journal-title":"J. Vis. Exp"},{"key":"10.1016\/j.preteyeres.2021.101029_bib421","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.preteyeres.2010.01.001","article-title":"Genetics and molecular pathology of Stargardt-like macular degeneration","volume":"29","author":"Vasireddy","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib422","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/genes10090654","article-title":"Molecular therapies for inherited retinal diseases\u2014current standing, opportunities and challenges","volume":"10","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib423","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1242\/dmm.017913","article-title":"Biology and therapy of inherited retinal degenerative disease: insights from mouse models","volume":"8","author":"Veleri","year":"2015","journal-title":"Dis. Model. Mech"},{"key":"10.1016\/j.preteyeres.2021.101029_bib424","doi-asserted-by":"crossref","first-page":"e1003040","DOI":"10.1371\/journal.pgen.1003040","article-title":"CNOT3 Is a Modifier of PRPF31 Mutations in Retinitis Pigmentosa with Incomplete Penetrance","volume":"8","author":"Venturini","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib425","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib426","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.stemcr.2016.03.001","article-title":"Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis","volume":"6","author":"V\u00f6lkner","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.preteyeres.2021.101029_bib427","first-page":"12584","article-title":"Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc. Natl. Acad. Sci. U","volume":"98","author":"Vollrath","year":"2001","journal-title":"S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib428","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228418","article-title":"Translational read-through therapy of rpgr nonsense mutations","volume":"21","author":"V\u00f6ssing","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib429","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","article-title":"The Spliceosome: Design Principles of a Dynamic RNP Machine","volume":"136","author":"Wahl","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib430","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1261\/rna.876308","article-title":"Splicing regulation: From a parts list of regulatory elements to an integrated splicing code","volume":"14","author":"Wang","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.preteyeres.2021.101029_bib431","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00018-015-1843-0","article-title":"Nonsense suppression therapies in ocular genetic diseases","volume":"72","author":"Wang","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib432","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jmedgenet-2013-101558","article-title":"Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing","volume":"50","author":"Wang","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib433","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1167\/iovs.14-15972","article-title":"Comprehensive molecular diagnosis of a large Chinese leber congenital amaurosis cohort","volume":"56","author":"Wang","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib434","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes9070360","article-title":"Application of Whole Exome and Targeted Panel Sequencing in the Clinical Molecular Diagnosis of 319 Chinese Families with Inherited Retinal Dystrophy and Comparison Study","volume":"9","author":"Wang","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2021.101029_bib435","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.preteyeres.2021.101029_bib436","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.8.2.21","article-title":"An Ophthalmic Targeted Exome Sequencing Panel as a Powerful Tool to Identify Causative Mutations in Patients Suspected of Hereditary Eye Diseases","volume":"8","author":"Wang","year":"2019","journal-title":"Transl. Vis. Sci. Technol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib437","doi-asserted-by":"crossref","first-page":"634478","DOI":"10.3389\/fcell.2021.634478","article-title":"Dominant RP in the Middle While Recessive in Both the N- and C-Terminals Due to RP1 Truncations: Confirmation, Refinement, and Questions","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib438","doi-asserted-by":"crossref","first-page":"e52611","DOI":"10.7554\/eLife.52611","article-title":"Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides","volume":"9","author":"Wangen","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.preteyeres.2021.101029_bib439","series-title":"Molecular and clinical analysis of 27 German patients with Leber congenital amaurosis. PLoS One 13, e0205380","author":"Weisschuh","year":"2018"},{"key":"10.1016\/j.preteyeres.2021.101029_bib440","series-title":"Genetic Architecture of Inherited Retinal Degeneration in Germany : A Large Cohort Study from a Single Diagnostic Center over a 9-year Period","first-page":"1514","author":"Weisschuh","year":"2020"},{"key":"10.1016\/j.preteyeres.2021.101029_bib441","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.23920","article-title":"Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation","volume":"41","author":"Weisschuh","year":"2020","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.preteyeres.2021.101029_bib442","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2021.101029_bib443","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.preteyeres.2011.11.005","article-title":"CNTF and retina","volume":"31","author":"Wen","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib444","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1098\/rstb.2011.0138","article-title":"Evolutionary optimization of speed and accuracy of decoding on the ribosome","volume":"366","author":"Wohlgemuth","year":"2011","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib445","first-page":"421","article-title":"Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy. Curr","volume":"13","author":"Wold","year":"2014","journal-title":"Gene Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib446","first-page":"8298","article-title":"Toward the therapeutic editing of mutated RNA sequences. Proc. Natl. Acad. Sci. U","volume":"92","author":"Woolf","year":"1995","journal-title":"S. A"},{"key":"10.1016\/j.preteyeres.2021.101029_bib447","first-page":"316","volume":"14","author":"Wu","year":"2006","journal-title":"Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy. Mol. Ther"},{"key":"10.1016\/j.preteyeres.2021.101029_bib448","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/eye.2009.270","article-title":"Long-term follow-up of a family with dominant X-linked retinitis pigmentosa","volume":"24","author":"Wu","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101029_bib449","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.ejhg.5200828","article-title":"Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and CACNA1F expression profiling in mouse retina","volume":"10","author":"Wutz","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib450","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1212\/NXG.0000000000000357","article-title":"A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation","volume":"5","author":"Xiao","year":"2019","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.preteyeres.2021.101029_bib451","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00439-014-1460-2","article-title":"Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing","volume":"133","author":"Xu","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.preteyeres.2021.101029_bib452","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40164-018-0122-9","article-title":"Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine","volume":"7","author":"Xu","year":"2018","journal-title":"Exp. Hematol. Oncol"},{"key":"10.1016\/j.preteyeres.2021.101029_bib453","first-page":"1163","article-title":"Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases. Expert Opin. Investig","volume":"29","author":"Xue","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.preteyeres.2021.101029_bib454","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exer.2016.05.020","article-title":"A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets. Exp","volume":"151","author":"Yau","year":"2016","journal-title":"Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib471","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-6606-7-45","article-title":"The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa","volume":"7","author":"Yoshida","year":"2014","journal-title":"Mol. brain"},{"key":"10.1016\/j.preteyeres.2021.101029_bib455","doi-asserted-by":"crossref","first-page":"14716","DOI":"10.1038\/ncomms14716","article-title":"Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1016\/j.preteyeres.2021.101029_bib456","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.preteyeres.2016.05.002","article-title":"Retinal stimulation strategies to restore vision: Fundamentals and systems","volume":"53","author":"Yue","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib457","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41436-020-0759-8","article-title":"Copy-number variation contributes 9 % of pathogenicity in the inherited retinal degenerations","volume":"22","author":"Zampaglione","year":"2020","journal-title":"Genet. Med"},{"key":"10.1016\/j.preteyeres.2021.101029_bib458","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2105-15-191","article-title":"Efficient design of meganucleases using a machine learning approach","volume":"15","author":"Zaslavskiy","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.preteyeres.2021.101029_bib459","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2014.09.001","article-title":"Congenital stationary night blindness: An analysis and update of genotype-phenotype correlations and pathogenic mechanisms","volume":"45","author":"Zeitz","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib460","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/humu.23735","article-title":"Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F-mediated inherited retinal disorders","volume":"40","author":"Zeitz","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2021.101029_bib461","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceb.2015.10.008","article-title":"Pluripotent stem cell-based disease modeling: Current hurdles and future promise","volume":"37","author":"Zeltner","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.preteyeres.2021.101029_bib462","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1167\/iovs.11-8182","article-title":"Analysis of the ABCA4 Gene by Next-Generation Sequencing","volume":"52","author":"Zernant","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib463","series-title":"Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration 404\u2013412","author":"Zernant","year":"2017"},{"key":"10.1016\/j.preteyeres.2021.101029_bib464","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1167\/iovs.15-18142","article-title":"Further consideration of the association between OR2W3 mutation and retinitis pigmentosa","volume":"56","author":"Zhang","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib465","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s13238-013-0011-2","article-title":"Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors","volume":"5","author":"Zhang","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.preteyeres.2021.101029_bib466","doi-asserted-by":"crossref","first-page":"32792","DOI":"10.1038\/srep32792","article-title":"Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1016\/j.preteyeres.2021.101029_bib467","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/cr.2017.57","article-title":"Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors","volume":"27","author":"Zhu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.preteyeres.2021.101029_bib468","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.3390\/ijms20225722","article-title":"Gene therapy in retinal dystrophies","volume":"20","author":"Ziccardi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2021.101029_bib469","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/genes10050377","article-title":"Retinal miRNA functions in health and disease","volume":"10","author":"Zuzic","year":"2019","journal-title":"Genes (Basel)"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946221000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946221000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:46:00Z","timestamp":1761173160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946221000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":464,"alternative-id":["S1350946221000902"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101029","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101029"}}